{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:52:48Z","timestamp":1792511568662,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.vaccine.2018.02.073","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:43:11Z","timestamp":1519605791000},"page":"1846-1852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity"],"prefix":"10.1016","volume":"36","author":[{"given":"Huafang","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.073_b0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/jama.2013.8042","article-title":"West Nile virus: review of the literature","volume":"310","author":"Petersen","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2018.02.073_b0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.meegid.2016.05.004","article-title":"Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas","volume":"43","author":"Ye","year":"2016","journal-title":"Infection, Genet Evol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2471\/BLT.16.182105","article-title":"Systematic analysis of protein identity between Zika virus and other arthropod-borne viruses","volume":"95","author":"Chang","year":"2017","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2018.02.073_b0020","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/503038","article-title":"West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003","volume":"42","author":"Bode","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.073_b0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tim.2006.05.004","article-title":"A genetic basis for human susceptibility to West Nile virus","volume":"14","author":"Diamond","year":"2006","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1471-2334-14-248","article-title":"West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes","volume":"14","author":"Hart","year":"2014","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.vaccine.2018.02.073_b0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.02.073_b0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/clinids\/19.3.500","article-title":"Antibody-dependent of enhancement of infection and the pathogenesis of viral disease","volume":"19","author":"Morens","year":"1994","journal-title":"Clin Inf Dis"},{"key":"10.1016\/j.vaccine.2018.02.073_b0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.02.073_b0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III. Pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (ARILVAX\u2122 and YF-VAX\u00ae) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Tropical Med Hygiene"},{"key":"10.1016\/j.vaccine.2018.02.073_b0055","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.073_b0060","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","article-title":"Structural basis of zika virus-specific antibody protection","volume":"166","author":"Zhao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2018.02.073_b0065","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.vaccine.2010.12.081","article-title":"Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease","volume":"29","author":"Alonso-Padilla","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.073_b0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/vir.0.80411-0","article-title":"Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein","volume":"86","author":"Chu","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2014\/952865","article-title":"A plant-produced antigen elicits potent immune responses against West Nile virus in mice","volume":"2014","author":"He","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2018.02.073_b0080","doi-asserted-by":"crossref","DOI":"10.3791\/50521-v","article-title":"Efficient Agroinfiltration of plants for high-level transient expression of recombinant proteins","author":"Leuzinger","year":"2013","journal-title":"J Visualized Exp"},{"key":"10.1016\/j.vaccine.2018.02.073_b0085","doi-asserted-by":"crossref","unstructured":"Chen Q, Dent M, Hurtado J, Stahnke J, McNulty A, Leuzinger K, et al. Transient Protein Expression by Agroinfiltration in Lettuce. Methods in molecular biology, Clifton, NJ; 2016; 1385: 55\u201367.","DOI":"10.1007\/978-1-4939-3289-4_4"},{"key":"10.1016\/j.vaccine.2018.02.073_b0090","doi-asserted-by":"crossref","unstructured":"Chen Q, Davis K. The potential of plants as a system for the development and production of human biologics F1000Research. 2016; 5. doi: 10.12688\/f1000research.8010.1.","DOI":"10.12688\/f1000research.8010.1"},{"key":"10.1016\/j.vaccine.2018.02.073_b0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.13031\/2013.26854","article-title":"Expression and purification of pharmaceutical proteins in plants","volume":"1","author":"Chen","year":"2008","journal-title":"Biol Eng"},{"key":"10.1016\/j.vaccine.2018.02.073_b0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2014\/256135","article-title":"Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes","volume":"2014","author":"Tuse","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2018.02.073_b0105","first-page":"10","article-title":"Gene delivery into plant cells for recombinant protein production","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2018.02.073_b0110","doi-asserted-by":"crossref","unstructured":"Chen Q. Recombinant Therapeutic Molecules Produced in Plants. Advances in Botanical Research, Academic Press; 2018; 86: 207\u201344. http:\/\/doi.org\/\/10.1016\/bs.abr.2017.11.006.","DOI":"10.1016\/bs.abr.2017.11.006"},{"key":"10.1016\/j.vaccine.2018.02.073_b0115","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1073\/pnas.0914503107","article-title":"Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice","volume":"107","author":"Lai","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.02.073_b0120","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","article-title":"Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus","volume":"35","author":"Yang","year":"2017","journal-title":"Vacccine"},{"key":"10.1016\/j.vaccine.2018.02.073_b0125","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1099\/jgv.0.000635","article-title":"Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity","volume":"97","author":"Dent","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0130","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1099\/vir.0.066084-0","article-title":"Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro","volume":"95","author":"Paul","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0135","article-title":"Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice","author":"Yang","year":"2017","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2018.02.073_b0140","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.02.073_b0145","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.073_b0150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2249.1997.4311446.x","article-title":"Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages","volume":"110","author":"Kreil","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","article-title":"Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine","volume":"25","author":"Mason","year":"1973","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0160","doi-asserted-by":"crossref","first-page":"474-478","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.02.073_b0165","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0170","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/JVI.02903-12","article-title":"A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice","volume":"87","author":"Pinto","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0175","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","author":"Minke","year":"2004","journal-title":"Arch Virol Suppl"},{"key":"10.1016\/j.vaccine.2018.02.073_b0180","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.02.073_b0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/ijms19010054","article-title":"Development of antibody therapeutics against flaviviruses","volume":"19","author":"Sun","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2018.02.073_b0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","article-title":"Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus","volume":"26","author":"Martina","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.073_b0195","doi-asserted-by":"crossref","first-page":"e93541","DOI":"10.1371\/journal.pone.0093541","article-title":"Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus","volume":"9","author":"He","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.02.073_b0200","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/pbi.12217","article-title":"Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants","volume":"12","author":"Lai","year":"2014","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2018.02.073_b0205","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/JVI.00286-09","article-title":"Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step","volume":"83","author":"Vogt","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0210","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.4049\/jimmunol.1000768","article-title":"TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis","volume":"185","author":"Demento","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/21645515.2014.983412","article-title":"Product review on the JE vaccine IXIARO","volume":"11","author":"Firbas","year":"2015","journal-title":"Human Vacc Immunother"},{"key":"10.1016\/j.vaccine.2018.02.073_b0225","doi-asserted-by":"crossref","first-page":"20695","DOI":"10.1073\/pnas.1117715108","article-title":"A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge","volume":"108","author":"Phoolcharoen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.02.073_b0230","doi-asserted-by":"crossref","unstructured":"Halstead SB. Dengue Antibody-Dependent Enhancement: Knowns and Unknowns. Microbiology spectrum 2014; 2.","DOI":"10.1128\/microbiolspec.AID-0022-2014"},{"key":"10.1016\/j.vaccine.2018.02.073_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.02.073_b0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika\u2013dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.02.073_b0245","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.02.073_b0250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 \u00c5 resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.02.073_b0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2018.02.073_b0260","doi-asserted-by":"crossref","first-page":"e1447","DOI":"10.1371\/journal.pntd.0001447","article-title":"Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay","volume":"6","author":"Lin","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.02.073_b0265","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1128\/JVI.00643-07","article-title":"Induction of epitope-specific neutralizing antibodies against West Nile virus","volume":"81","author":"Oliphant","year":"2007","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:54Z","timestamp":1759400694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0264410X18302603"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}